Stryker receives subpoena and warning letter
This article was originally published in Clinica
Orthopaedics firm Stryker has been handed a subpoena by the attorney general of New Jersey, requesting information relating to its financial relationship with physicians participating in certain clinical trials. The Kalamazoo, Michigan-based company is currently working on its response to the subpoena, which it claims has been issued to other major medical device manufacturing companies. Separately, Stryker has received a warning letter from the US FDA in relation to its craniomaxillofacial implant products. Full details of the warning were not disclosed and a spokesperson for the company told Clinica that it would not be making any further comments. Earlier this year, Stryker came under investigation from the US attorney’s office for the district of Massachusetts following claims of illegal and inaccurate promotion of its orthobiological products (see Clinica No 1336, p 3).